Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.

Stefic K, Bouvin-Pley M, Essat A, Visdeloup C, Moreau A, Goujard C, Chaix ML, Braibant M, Meyer L, Barin F.

J Virol. 2019 Jan 4;93(2). pii: e01492-18. doi: 10.1128/JVI.01492-18. Print 2019 Jan 15.

PMID:
30404804
2.

Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.

Stefic K, Novelli S, Mahjoub N, Seng R, Molina JM, Cheneau C, Barin F, Chaix ML, Meyer L, Delaugerre C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group .

J Infect Dis. 2018 May 5;217(11):1793-1797. doi: 10.1093/infdis/jiy120.

PMID:
29509924
3.

[Trispecific broadly neutralizing antibodies for HIV immunoprophylaxis and immunotherapy?]

Barin F, Stefic K.

Med Sci (Paris). 2018 Feb;34(2):109-111. doi: 10.1051/medsci/20183402002. Epub 2018 Feb 16. French. No abstract available.

PMID:
29451475
4.

Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties.

Stefic K, Chaillon A, Bouvin-Pley M, Moreau A, Braibant M, Bastides F, Gras G, Bernard L, Barin F.

PLoS One. 2017 Aug 25;12(8):e0181680. doi: 10.1371/journal.pone.0181680. eCollection 2017.

5.

Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.

Stefic K, Salmona M, Capitao M, Splittgerber M, Maakaroun-Vermesse Z, Néré ML, Bernard L, Chaix ML, Barin F, Delaugerre C.

J Antimicrob Chemother. 2017 Mar 1;72(3):850-854. doi: 10.1093/jac/dkw507.

PMID:
27999055

Supplemental Content

Loading ...
Support Center